Exemestane
About
Therapy type: Hormone therapy
Therapy strategy: Aromatase inhibition
Mappings
NCI Thesaurus: Exemestane (coding:ncit:C1097)
RxNorm: exemestane (coding:rxcui:258494, coding:omop:1398399)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | ER positive, HER2-negative | Invasive Breast Carcinoma | Everolimus, Exemestane | |
| EMA (1) FDA (2) | HER2-negative, PR positive | Invasive Breast Carcinoma | Everolimus, Exemestane | |
| EMA (1) FDA (2) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Everolimus, Exemestane | |
| EMA (1) FDA (2) | ER positive, HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Exemestane | |
| EMA (1) FDA (2) | ER positive, HER2-negative | Invasive Breast Carcinoma | Abemaciclib, Exemestane | |
| EMA (1) FDA (2) | HER2-negative, PR positive | Invasive Breast Carcinoma | Abemaciclib, Exemestane |